FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

14765311000001103: Lercanidipine 10mg tablets 25 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51701901000001115 Lercanidipine 10mg tablets 25 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
51702001000001111 Lercanidipine 10mg tablets 25 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lercanidipine 10mg tablets 25 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Is pack of Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has active ingredient Lercanidipine hydrochloride false Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has VMP Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has specific active ingredient Lercanidipine hydrochloride true Inferred relationship Existential restriction modifier
Lercanidipine 10mg tablets 25 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zanidip 10mg tablets (Sigma Pharmaceuticals Plc) 25 tablet Is a True Lercanidipine 10mg tablets 25 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start